Paper29362136
The diamond anniversary of tissue transglutaminase: a protein of many talents.
Katt WP and 2 others. Drug Discov Today, 2018. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. The diamond anniversary of tissue transglutaminase: a protein of many talents. Papers, record 29362136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29362136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Transglutaminases | Major topic |
| Amines | |
| Animals | |
| Disease Progression | |
| GTP-Binding Proteins | |
| Glutamine | |
| Humans | |
| Neoplasms |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA201402 | NCI NIH HHS | United States | R01CA201402 | PubMed and NIH |
Source NIH RePORTER
References108
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19568436 | Intracellular localization and conformational state of transglutaminase 2: implications for cell death. | PLoS One | 2009 | https://conductscience.org/library/papers/19568436 | PubMed |
| 2 | 23877317 | TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells. | Neuro Oncol | 2013 | https://conductscience.org/library/papers/23877317 | PubMed |
| 3 | 18667446 | Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling. | Carcinogenesis | 2008 | https://conductscience.org/library/papers/18667446 | PubMed |
| 4 | 21321991 | Wnt10b activates the Wnt, notch, and NFκB pathways in U2OS osteosarcoma cells. | J Cell Biochem | 2011 | https://conductscience.org/library/papers/21321991 | PubMed |
| 5 | 12679341 | Roles of calcium ions in the activation and activity of the transglutaminase 3 enzyme. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12679341 | PubMed |
| 6 | 6141210 | Induction of tissue transglutaminase in human peripheral blood monocytes. | J Exp Med | 1984 | https://conductscience.org/library/papers/6141210 | PubMed |
| 7 | 11520809 | Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. | Blood | 2001 | https://conductscience.org/library/papers/11520809 | PubMed |
| 8 | 1670766 | Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. | J Biol Chem | 1991 | https://conductscience.org/library/papers/1670766 | PubMed |
| 9 | 19838207 | Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells. | Oncogene | 2010 | https://conductscience.org/library/papers/19838207 | PubMed |
| 10 | 12576551 | Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12576551 | PubMed |
| 11 | 26893378 | The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26893378 | PubMed |
| 12 | 22158040 | Sp1 expression regulates lung tumor progression. | Oncogene | 2012 | https://conductscience.org/library/papers/22158040 | PubMed |
| 13 | 18594947 | Transdab wiki: the interactive transglutaminase substrate database on web 2.0 surface. | Amino Acids | 2009 | https://conductscience.org/library/papers/18594947 | PubMed |
| 14 | 25613900 | Proteomics. Tissue-based map of the human proteome. | Science | 2015 | https://conductscience.org/library/papers/25613900 | PubMed |
| 15 | 16294209 | Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. | Cell Death Differ | 2006 | https://conductscience.org/library/papers/16294209 | PubMed |
| 16 | 2172239 | A novel guanine nucleotide-binding protein coupled to the alpha 1-adrenergic receptor. I. Identification by photolabeling or membrane and ternary complex preparation. | J Biol Chem | 1990 | https://conductscience.org/library/papers/2172239 | PubMed |
| 17 | 15069073 | Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15069073 | PubMed |
| 18 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 20 | 16951195 | Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway. | Cancer Res | 2006 | https://conductscience.org/library/papers/16951195 | PubMed |
| 21 | 17240993 | Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor. | Biochemistry | 2007 | https://conductscience.org/library/papers/17240993 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41142754 | Identification of transglutaminase 2 mediated polyaminated proteins in a hepatocellular cancer cell line. | Comput Struct Biotechnol J | 2025 | https://conductscience.org/library/papers/41142754 | PubMed |
| 40610434 | Transglutaminase 2 function in glioblastoma tumor efferocytosis. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/40610434 | PubMed |
| 39769187 | The Search for a Universal Treatment for Defined and Mixed Pathology Neurodegenerative Diseases. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769187 | PubMed |
| 39134806 | Distinct conformational states enable transglutaminase 2 to promote cancer cell survival versus cell death. | Commun Biol | 2024 | https://conductscience.org/library/papers/39134806 | PubMed |
| 38667282 | Biological Implications and Functional Significance of Transglutaminase Type 2 in Nervous System Tumors. | Cells | 2024 | https://conductscience.org/library/papers/38667282 | PubMed |
| 37169024 | Transglutaminase 2 regulates terminal erythroid differentiation via cross-linking activity. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37169024 | PubMed |
| 37144817 | Chaotic advection mixer for capturing transient states of diverse biological macromolecular systems with time-resolved small-angle X-ray scattering. | IUCrJ | 2023 | https://conductscience.org/library/papers/37144817 | PubMed |
| 36846375 | Novel irreversible peptidic inhibitors of transglutaminase 2. | RSC Med Chem | 2023 | https://conductscience.org/library/papers/36846375 | PubMed |
| 36846370 | The war on hTG2: warhead optimization in small molecule human tissue transglutaminase inhibitors. | RSC Med Chem | 2023 | https://conductscience.org/library/papers/36846370 | PubMed |
| 36838622 | Peptidic Inhibitors and a Fluorescent Probe for the Selective Inhibition and Labelling of Factor XIIIa Transglutaminase. | Molecules | 2023 | https://conductscience.org/library/papers/36838622 | PubMed |
| 36499332 | A Central Contribution of TG2 Activity to the Antiproliferative and Pro-Apoptotic Effects of Caffeic Acid in K562 Cells of Human Chronic Myeloid Leukemia. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36499332 | PubMed |
| 36471278 | TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/LDH pathway. | BMC Cancer | 2022 | https://conductscience.org/library/papers/36471278 | PubMed |
| 35647547 | Structure-activity relationships of hydrophobic alkyl acrylamides as tissue transglutaminase inhibitors. | RSC Med Chem | 2022 | https://conductscience.org/library/papers/35647547 | PubMed |
| 35626704 | Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease. | Cells | 2022 | https://conductscience.org/library/papers/35626704 | PubMed |
| 35562866 | Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35562866 | PubMed |
| 35340676 | Exploring the Role of Transglutaminase in Patients with Glioblastoma: Current Perspectives. | Onco Targets Ther | 2022 | https://conductscience.org/library/papers/35340676 | PubMed |
| 35122964 | Latent TGFβ complexes are transglutaminase cross-linked to fibrillin to facilitate TGFβ activation. | Matrix Biol | 2022 | https://conductscience.org/library/papers/35122964 | PubMed |
| 33095824 | Serotonin stimulated parathyroid hormone related protein induction in the mammary epithelia by transglutaminase-dependent serotonylation. | PLoS One | 2020 | https://conductscience.org/library/papers/33095824 | PubMed |
| 32898582 | Transglutaminase-Mediated Cross-Linking of Tropoelastin to Fibrillin Stabilises the Elastin Precursor Prior to Elastic Fibre Assembly. | J Mol Biol | 2020 | https://conductscience.org/library/papers/32898582 | PubMed |
| 32210142 | Structures of Human Transglutaminase 2: Finding Clues for Interference in Cross-linking Mediated Activity. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32210142 | PubMed |
Genes44
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29362136
GET https://conductscience.org/api/papers/v1/29362136/references?page=2